Sign Up to like & get
recommendations!
0
Published in 2021 at "Scandinavian journal of clinical and laboratory investigation"
DOI: 10.1080/00365513.2021.2003855
Abstract: The use of direct factor Xa inhibitors rivaroxaban and apixaban (XABANs) has rapidly increased; however, there is no validated test available to monitor the effect on hemostasis. This study aims to assess how hemostatic management…
read more here.
Keywords:
act 120;
factor inhibitors;
xaban patients;
direct factor ... See more keywords